2021 annual financial data
Anika Therapeutics 2021 Operating cash flow margin
Direct answer
Operating cash flow margin was 5.68%.
Operating income was 2.62M USD and net income was 4.13M USD.
Operating cash flow was 8.4M USD.
Get free Anika Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 147.79M USD
- Operating income
- 2.62M USD
- Net income
- 4.13M USD
- Operating cash flow
- 8.4M USD